IDEAYA Biosciences, Inc, a precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced further interim results from its Phase...
Tempus, a leader in artificial intelligence (AI) and precision medicine, today announced a multi-year, strategic collaboration with Pfizer in which the two companies are...
Valneva SE, a specialty vaccine company, and Pfizer Inc. announced that they have entered into an Equity Subscription Agreement and have updated the terms...
CStone Pharmaceuticals, a leading biopharmaceutical company focused on research, development, and commercialization of innovative immuno-oncology therapies and precision medicines, and Pfizer Inc. announced that...
The National Comprehensive Cancer Network Oncology Research Program (ORP) announced a collaboration with Pfizer Global Medical Grants (Pfizer) that awards new grants to advance...
